The Human Cell Atlas, developed by an international consortium of cytologists, molecular biologists, and data scientists, ...

Phase 1/2 clinical trial in Geographic Atrophy currently underway – – Kriya is developing KRIYA-825 as a potential one-time gene therapy, delivered by suprachoroidal injection, expressing a fusion ...

Milestone highlights Acentra Health’s pivotal role in supporting state Medicaid modernization and eligibility platform transformation. MCLEAN, Va., May 08, 2025 (GLOBE NEWSWIRE) ...

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), today announced that its shareholders approved all proposals at the Annual General Meeting of Shareholders (AGM) 2025, including: The ...

Most cutting steroids increase your metabolic rate, helping your body use fat for energy more efficiently. Compounds like ...

Arialief for Neuropathy is a doctor-recommended joint support supplement made with natural, clinically backed ingredients ...

AIM ImmunoTech Inc. (NYSE American: AIM) (OTC Pink: AIMI) (“AIM” or the “Company”) today announced the presentation of clinical trial data involving AIM’s drug Ampligen by Pawel Kalinski, MD, PhD, at ...

Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and ...

New patent filing secures composition of matter protection for AZD5904, a potent myeloperoxidase inhibitor in Conduit’s pipeline, unlocking up to 20 years of new IP runway and enabling enhanced ...

This XRP payment initiative is supported by Wellgistics Health’s $50 million Equity Line of Credit (ELOC), the proceeds of which may be utilized to further develop and unlock programmable liquidity ...

Three-year program examined opportunities to integrate artificial intelligence technology into future generations of ReWalk Exoskeletons MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, May 08, 2025 ...

The Company is also winding down its clinical and manufacturing operations, beginning immediately, including its ongoing clinical trials. The decision to discontinue clinical operations is not due to ...